The average one-year price target for Twist Bioscience (NasdaqGS:TWST) has been revised to $48.35 / share. This is an ...

Twist Bioscience Corporation Q1 2026 revenue rose 17% and guidance increased. Click for this updated look at TWST stock ...

Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced financial results ...

The inducement plan is used exclusively for the grant of equity awards to individuals who were not previously employees of Twist, or following a bona fide period of non-employment, as an inducement ...

Twist Bioscience Corporation (NASDAQ:TWST) Q1 2026 Earnings Call Transcript February 2, 2026 Twist Bioscience Corporation ...

Twist Bioscience raised fiscal 2026 sales guidance from $425 million-$435 million to $435 million-$440 million versus the consensus of $431.39 million. The guidance expects the revenue increase versus ...

SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Twist Bioscience Corp. (TWST) on Monday reported a loss ...

Twist Bioscience (TWST) delivered earnings and revenue surprises of -5.26% and -0.05%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Ongoing combination of Twist NGS library preparation kits with firefly will continue to expand SPT Labtech’s portfolio of ...

Twist Bioscience (NASDAQ: TWST) released its Q1 earnings on Monday, February 2, 2026 at 07:15 AM. Here's what's important ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...

The biotech company posted revenue of $103.7 million for the quarter ended December 31, 2025, surpassing the analyst consensus of $100.72 million and representing a 17% increase from $88.7 million in ...